
23 Feb Avery Therapeutics
Jordan Lancaster, Ph.D., CEO
Oct. 10 | 10:00am | Rentschler ATMP Ballroom
Tucson, AZ
(Private)
Avery Therapeutics is a late pre-clinical stage company dedicated to improving the lives of patients with cardiovascular disease through a novel immunomodulatory biologic cell therapy platform.